This is a parallel group, single institution, prospective clinical study. The purpose of this study is to assess whether the Jawbone Up 24, a consumer based accelerometer, can be a feasible tool to study physical activity in cancer patients and patients with Amyotrophic Lateral Sclerosis (ALS).
Study Type
OBSERVATIONAL
Enrollment
40
Duke University Medical Center
Durham, North Carolina, United States
Compliance rate of cancer and ALS patients using the device during a 14 week period.
Time frame: 14 weeks
Number of steps per day in cancer patients.
Time frame: 14 weeks
Karnofsky performance status in cancer patients.
Time frame: 14 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.